Product analysis
AI assessment of the formula, label and price. How scoring works
Nutrient Quality41
Ingredient Transparency100
Value For Money66
Customer Satisfaction73
Product Focus59
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $0.26
- Customer rating
- 4.7 · 125 ratings
Goals
OptiFerin-C is a targeted energy option when iron deficiency contributes to fatigue. It supplies 28 mg iron, with 100 mg vitamin C alongside it to support iron absorption.
OptiFerin-C has a focused hair-health role when iron deficiency contributes to shedding. Its 28 mg iron bisglycinate supplies iron to address that gap. Vitamin C at 100 mg supports iron absorption as a complementary nutritional function.
OptiFerin-C has a narrow productivity role through iron support when low iron contributes to fatigue and poor concentration. Each capsule supplies 28 mg of iron as bisglycinate. The practical value depends on iron need, which the supplement label cannot establish.
OptiFerin-C is a narrower immunity choice for someone who needs to correct low iron. Its 28 mg of iron as bisglycinate can help restore immune-cell function impaired by deficiency; the label alone cannot show that need. Vitamin C at 100 mg supports iron absorption, making it a useful companion to the iron.
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin C (Calcium Ascorbate) | 100 mg | |
Calcium (Calcium Ascorbate) | 11 mg | |
Iron (Iron Bisglycinate) | 28 mg |
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial.
- The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT.
- Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP).
- Effect of iron therapy on fatigue symptoms in non-anaemic iron deficient women of reproductive age- A Randomized Controlled Trial.
- Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage.
- Ferric carboxymaltose in patients with heart failure and iron deficiency.
- Marginal iron deficiency without anemia impairs aerobic adaptation among previously untrained women.
- Ferric Carboxymaltose Versus Ferrous Fumarate in Anemic Children with Inflammatory Bowel Disease: The POPEYE Randomized Controlled Clinical Trial.
- Daily iron supplementation for improving anaemia, iron status and health in menstruating women.
- Altered metabolic response of iron-depleted nonanemic women during a 15-km time trial.
- Inter-individual variability in redox and performance responses after antioxidant supplementation: A randomized double blind crossover study.
- Antioxidant supplementation, redox deficiencies and exercise performance: A falsification design.
- A significant relationship between plasma vitamin C concentration and physical performance among Japanese elderly women.
- Low vitamin C values are linked with decreased physical performance and increased oxidative stress: reversal by vitamin C supplementation.
- Low dietary vitamin C intake is associated with low muscle strength among elderly Korean women.
- The Association Between Alopecia Areata and Iron Deficiency Anemia: A Large-Scale Population-Based Case-Control Study.
- Iron Deficiency and Nonscarring Alopecia in Women: Systematic Review and Meta-Analysis.
- Comparative Analysis of Postoperative Hair Loss and Micronutrient Deficiencies After One-Anastomosis Gastric Bypass Versus Sleeve Gastrectomy.
- Assessment of Serum Ferritin Levels in Female Patients With Telogen Effluvium.
- Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia.